Antibody conjugates and malignant disease / by 399966 Magerstadt, Michael

Subjects:

Bispecific antibody drug conjugates: Making 1+1>2 by Yilin Gu, Zhijia Wang, Yuxi Wang

Subjects: Get full text

Antibody-drug conjugates: beyond current approvals and potential future strategies by Siddharth Menon, Sagun Parakh, Andrew M. Scott, Hui K. Gan

Subjects: “…antibody-drug conjugates…”
Get full text

Current Status and Future Prospects of TROP-2 ADCs in Lung Cancer Treatment by Li M, Jin M, Peng H, Wang H, Shen Q, Zhang L

Subjects: Get full text

Recent advances in antibody-drug conjugates for the treatment of gastric cancer by Xiao Lihai, Xia Gang, Wang Jiancheng

Subjects: “…antibody-drug conjugates…”
Get full text

HER2-targeted therapies in cancer: a systematic review by Kunrui Zhu, Xinyi Yang, Hebei Tai, Xiaorong Zhong, Ting Luo, Hong Zheng

Subjects: Get full text

Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer... by Audrey Nathania Johan, Yi Li

Subjects: Get full text

Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates by Tomohiro Fujii, Calliste Reiling, Colette Quinn, Michal Kliman, Brian A. Mendelsohn, Yutaka Matsuda

Subjects: “…antibody-drug conjugates…”
Get full text

The Chemistry Behind ADCs by Vesela Kostova, Patrice Désos, Jérôme-Benoît Starck, Andras Kotschy

Subjects: “…antibody-drug conjugates…”
Get full text

First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors by Chiara Testa, Anna Maria Papini, Reinhard Zeidler, Daniela Vullo, Fabrizio Carta, Claudiu T. Supuran, Paolo Rovero

Subjects: Get full text

Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress by Yurou Chu, Xiangxiang Zhou, Xin Wang

Subjects: “…Antibody-drug conjugates…”
Get full text

Monoclonal War: The Antibody Arsenal and Targets for Expanded Application by Eric H. Rosenn, Mickael Benhaim, Allison Siegel, David A. Stein, Joseph S. Leonard, Erik Katcher, Dania Halperin, Zachary Mostel

Subjects: Get full text

Antibody‐Drug Conjugates to Treat Bacterial Biofilms via Targeting and Extracellular Drug Release by Anne Tvilum, Mikkel I. Johansen, Lærke N. Glud, Diana M. Ivarsen, Amanda B. Khamas, Sheiliza Carmali, Snehit Satish Mhatre, Ane B. Søgaard, Emma Faddy, Lisanne deVor, Suzan H. M. Rooijakkers, Lars Østergaard, Nis P. Jørgensen, Rikke L. Meyer, Alexander N. Zelikin

Subjects: “…antibody‐drug‐conjugates…”
Get full text

Second-line antibody-drug conjugates for the treatment of metastatic human papillomavirus-independent gastric-type adenocarcinoma of cervix: The Singapore experience by Daniel Jia Ming Ang, Ke Xin Bok, Shing Lih Wong, Yihan Li, Adele Wong, Yen Ching Yeo, Junjie Wang, Ieera Madan Aggarwal, Jack Junjie Chan

Subjects: “…Antibody-drug conjugates…”
Get full text

Antibody–drug conjugates in solid tumors: a look into novel targets by Carmen Criscitiello, Stefania Morganti, Giuseppe Curigliano

Subjects: Get full text

Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations by Andrea D’Arienzo, Annarita Verrazzo, Martina Pagliuca, Fabiana Napolitano, Sara Parola, Martina Viggiani, Roberta Caputo, Fabio Puglisi, Mario Giuliano, Lucia Del Mastro, Grazia Arpino, Michelino De Laurentiis, Filippo Montemurro

Subjects: “…Antibody drug conjugates…”
Get full text

Recent developments in chemical conjugation strategies targeting native amino acids in proteins and their applications in antibody-drug conjugates by Kang, Min Sun, Kong, Theresa Wai See, Khoo, Joycelyn Yi Xin, Loh, Teck-Peng

Subjects: Get full text

Antibody-drug conjugates: the clinical development in gastric cancer by Yingze Zhu, Miao Zhou, Wenyue Kong, Congling Li

Subjects: “…antibody-drug conjugates…”
Get full text

Chemical Artificial Internalizing Receptors for Primary T Cells by Pere Monge, Anne Tvilum, Ane Bretschneider Søgaard, Kaja Borup Løvschall, Morten T. Jarlstad Olesen, Alexander N. Zelikin

Subjects: “…antibody–drug conjugates…”
Get full text

Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist’s Perspective by Andrew T. Lucas, Amber Moody, Allison N. Schorzman, William C. Zamboni

Subjects: “…antibody-drug conjugates…”
Get full text